The Yin and Yang of the Opioid Growth Regulatory System: Focus on Diabetes - The Lorenz E. Zimmerman Tribute Lecture

Joseph W. Sassani, Patricia J. Mc Laughlin, Ian S. Zagon

Research output: Contribution to journalArticle

10 Scopus citations

Abstract

The Opioid Growth Regulatory System consists of opioid growth factor (OGF), [Met5]-enkephalin, and its unique receptor (OGFr). OGF inhibits cell division when bound to OGFr. Conversely, blockade of the interaction of OGF and OGFr, using the potent, long-acting opioid receptor antagonist, naltrexone (NTX), results in increased DNA synthesis and cell division. The authors have demonstrated both in vitro and in vivo that the addition of exogenous OGF or an increase in available OGFr decreases corneal epithelial cell division and wound healing. Conversely, blockade of the OGF-OGFr interaction by NTX or a decrease in the production of the OGFr increases corneal epithelial cell division and facilitates corneal epithelial wound healing. The authors also have demonstrated that depressed corneal and cutaneous wound healing, dry eye, and abnormal corneal sensitivity in type 1 and type 2 diabetes in animals can be reversed by OGF-OGFr blockade by NTX. Thus, the function of the Opioid Growth Regulatory System appears to be disordered in diabetic animals, and its function can be restored with NTX treatment. These studies suggest a fundamental role for the Opioid Growth Regulatory System in the pathobiology of diabetic complications and a need for studies to elucidate this role further.

Original languageEnglish (US)
Article number9703729
JournalJournal of Diabetes Research
Volume2016
DOIs
StatePublished - Jan 1 2016

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Fingerprint Dive into the research topics of 'The Yin and Yang of the Opioid Growth Regulatory System: Focus on Diabetes - The Lorenz E. Zimmerman Tribute Lecture'. Together they form a unique fingerprint.

  • Cite this